首页 > 市场调查报告书 > 医疗设备

手术用器具

内视镜逆行性胰造影（ERCP）市场规模、份额和成长分析（按产品类型、手术方式、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1897644

内视镜逆行性胰造影（ERCP）市场规模、份额和成长分析（按产品类型、手术方式、最终用户和地区划分）－2026-2033年产业预测

Endoscopic Retrograde Cholangiopancreatography Market Size, Share, and Growth Analysis, By Product Type (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球内视镜逆行性造影(ERCP) 市场规模预计在 2024 年达到 16.5 亿美元，从 2025 年的 18.1 亿美元成长到 2033 年的 38.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 9.8%。

人们对微创手术技术的日益青睐推动了内视镜逆行性造影术（ERCP）需求的成长，促进了市场扩张。 ERCP手术量的成长主要归功于其诸多优势，例如与传统手术相比，恢復期更短、併发症率更低。此外，肝癌等疾病的日益普及也凸显了对先进诊断和治疗方案的迫切需求。随着医疗技术的不断创新，ERCP市场预计将迎来显着成长，这反映了医疗实践朝着更有效、更微创的方向发展，这些实践优先考虑患者疗效并提高整体医疗效率。

全球内视镜逆行性胰造影（ERCP）市场驱动因素

全球内视镜逆行性造影(ERCP) 市场成长的驱动力在于，人们对胰臟、肝臟、胆囊和胆管疾病的先进诊断和治疗方案的需求不断增长。这项创新技术结合了内视镜和透视技术，使医疗专业人员能够有效地观察和治疗影响胰胆系统的疾病。 ERCP 使用柔性照明内视镜并结合 X 光成像，可对这些重要器官进行详细评估，进而改善治疗效果。透过微创方式诊断和治疗复杂疾病的能力，正促使越来越多的医疗机构采用这项技术，从而推动市场成长和扩张。

限制全球内视镜逆行性胰造影（ERCP）市场的因素

全球内视镜逆行性造影(ERCP) 市场的成长面临许多挑战，主要原因是各国监管机构实施了严格的指导方针。这些法规阻碍了创新技术的应用，因为合规性需要进行广泛的测试并严格遵守安全性和有效性标准。因此，新医疗设备的核准流程复杂且耗时。儘管有这些监管限制，市场也受到一些正面因素的影响。例如，开发中国家可支配收入的成长是推动市场成长的主要因素，这有助于提高医疗保健服务的可近性并改善整体医疗保健效果。

全球内视镜逆行性胰造影（ERCP）市场趋势

全球内视镜逆行性胰造影（ERCP）市场预计将迎来显着成长，这主要得益于主要企业的策略性倡议。主要市场参与企业正致力于推出创新产品、建立合作关係、进行併购活动，旨在拓展产品线并改善患者预后。例如，一家专注于止血解决方案的科技公司与一家成熟的内视镜设备製造商之间的合作，凸显了各方致力于推进治疗方法发展的决心。这一趋势反映了医疗保健领域正朝着整合尖端技术、促进跨领域合作的方向发展，最终目标是提高消化器官系统介入手术的效率和安全性。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Olympus Corporation（Japan）
CONMED Corporation（United States）
Fujifilm Holdings Corporation（Japan）
HOYA Corporation（Japan）
Boston Scientific Corporation（United States）
Johnson & Johnson（United States）
Medtronic PLC（Ireland）
Cook Medical（United States）
STERRIS PLC（United States）
TeleMed Systems Inc.（United States）
DCC Healthcare（Medi-Globe GmbH）（Ireland）
Huger Medical Instrument Co. Ltd（China）
SonoScape Medical Corporation（China）
KARL STORZ SE & Co. KG（Germany）
Ambu A/S（Denmark）
B. Braun Melsungen AG（Germany）
PENTAX Medical（Japan）
Hitachi Ltd.（Japan）
Canon Medical Systems Corporation（Japan）
Sony Corporation（Japan）

结论与建议

简介目录

Product Code: SQMIG35A2748

Global Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.65 Billion in 2024 and is poised to grow from USD 1.81 Billion in 2025 to USD 3.82 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The growing preference for minimally invasive surgical techniques is driving an increased demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, leading to a burgeoning market. This rise in ERCP interventions is largely attributed to the benefits associated with these approaches, including shorter recovery times and a lower incidence of complications relative to traditional surgeries. Moreover, the increasing prevalence of conditions like liver cancer underscores the urgent requirement for advanced diagnostic and therapeutic options. As healthcare continues to innovate, the ERCP market is positioned for substantial growth, reflecting a broader trend towards more effective and less invasive medical practices that prioritize patient outcomes and enhance overall healthcare efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endoscopic Retrograde Cholangiopancreatography Market Segments Analysis

Global Endoscopic Retrograde Cholangiopancreatography Market is segmented by Product Type, Procedure, End Users and region. Based on Product Type, the market is segmented into Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices and Others. Based on Procedure, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialtation, Pancreatic Sphincterotomy, Pancreatic Duct Stenting and Pancreatic Duct Dilatation. Based on End Users, the market is segmented into Hospitals, Ambulatory Surgery Centers & Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is driven by the increasing demand for advanced diagnostic and therapeutic solutions targeting disorders of the pancreas, liver, gallbladder, and bile ducts. This innovative technique combines endoscopic and fluoroscopic methods, allowing healthcare professionals to visualize and treat conditions affecting the pancreatobiliary system effectively. By employing a flexible, illuminated endoscope alongside X-ray imaging, ERCP provides a detailed assessment of these critical organs, enhancing treatment outcomes. The ability to diagnose and manage complex maladies with a minimally invasive approach is attracting more healthcare facilities to adopt this technology, thereby fueling market growth and expansion.

Restraints in the Global Endoscopic Retrograde Cholangiopancreatography Market

The growth of the global endoscopic retrograde cholangiopancreatography market faces significant challenges due to strict regulatory guidelines enforced by governing bodies in various countries. These regulations create obstacles for the introduction of innovative technologies, as compliance demands extensive testing and strict adherence to safety and efficacy standards. This results in a complicated and lengthy approval process for new medical devices. Despite these regulatory constraints, there are positive influences on the market, including an increase in disposable income in developing countries, which has become a key driver of market growth, fostering greater accessibility and improving overall healthcare outcomes.

Market Trends of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is poised for substantial growth driven by strategic initiatives from leading players. Key industry participants are focusing on innovative product launches, partnerships, mergers, and acquisitions to enhance their offerings and improve patient outcomes. Collaborative ventures, such as those between technology firms specializing in hemostasis solutions and established endoscopic equipment manufacturers, underscore a commitment to advancing treatment methodologies. This trend reflects a broader movement within the healthcare sector towards integrating cutting-edge technologies and fostering collaboration, ultimately aiming to optimize procedural efficiency and enhance the safety of gastrointestinal interventions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Product Type & CAGR (2026-2033)

Market Overview
Endoscopes
Endotherapy Devices
- Sphincterotomes
- Lithotripter
- Stents
- Cannulas
- Forceps
- Snares
- Catheters
- Guiding Wires
- Balloons
- Baskets
Visualization Systems
Energy Devices
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Procedure & CAGR (2026-2033)

Market Overview
Biliary Sphincterotomy
Biliary Stenting
Biliary Dialtation
Pancreatic Sphincterotomy
Pancreatic Duct Stenting
Pancreatic Duct Dilatation

Global Endoscopic Retrograde Cholangiopancreatography Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgery Centers & Clinics
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size & CAGR (2026-2033)

North America (Product Type, Procedure, End Users)
- US
- Canada
Europe (Product Type, Procedure, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Procedure, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Procedure, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Procedure, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CONMED Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOYA Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERRIS PLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TeleMed Systems Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DCC Healthcare (Medi-Globe GmbH) (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Huger Medical Instrument Co. Ltd (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonoScape Medical Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ambu A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments